Skip to main content
. 2023 May 31;136(14):1699–1707. doi: 10.1097/CM9.0000000000002674

Figure 2.

Figure 2

The nomogram of predicting OS in patients with postoperative BCBM. (A) Survival nomogram for the prediction of 1-year, 3-year, and 5-year OS in BM patients. (B) Dynamic nomogram of predicting OS in patients with postoperative BCBM. BM: Brain metastasis; BCBM: Breast cancer brain metastasis; HER2: Human epidermal growth factor receptor 2; OS: Overall survival; TNBC: Triple negative breast cancer.